{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:28:01Z","timestamp":1780990081002,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000866","name":"IAVI","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000866","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>We anticipate large efficacy trials of novel HIV vaccines that have shown acceptable safety profiles. We determined willingness to participate (WTP) in future HIV vaccine efficacy trials among HIV negative female sex workers (FSWs) in Kampala Uganda.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We conducted a case control study in the Good Health for Women Project cohort. Cases received HIV prevention services and, enrolled in a 12-month simulated vaccine efficacy trial (SiVET) that used Hepatitis B vaccine; they underwent vaccine trial procedures as would be in an actual trial. Controls received similar health services but did not enroll in SiVET. We matched cases and controls (ratio 2:1) for age and duration in the cohort. We described a hypothetical HIV vaccine trial to cases (after 9\u2009months in SiVET) and controls including trial attributes: randomization, delaying pregnancy, frequent blood draws (80-100mls) and study visits for 3\u2009years. We compared WTP and willingness for vaccine trial attributes by case\/control using chi-squared or Fisher\u2019s exact tests and fitted conditional logistic regression models to determine independent predictors of WTP.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We analyzed data for 311 volunteers (219 cases, 92 controls); median age 27\u2009years (IQR: 23\u201332), 39.9% had \u2265secondary education, 57.9% had sex work as their main job and 81.9% used illicit drugs. Compared to controls, more cases had lived in the community for &gt;\u20091\u2009year, (85.4% vs 64.1%; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) and fewer cases reported illicit drug use in the past 3\u2009months, (79.0% vs 89.1%; <jats:italic>p<\/jats:italic>\u2009=\u20090.03). Overall, 278 (89.4%) volunteers expressed WTP in an HIV vaccine trial, the most common reason being hope of protection against HIV. More cases than controls (58.2% vs 44.7%) did not need to consult anyone before trial participation (<jats:italic>p<\/jats:italic>\u2009=\u20090.03); cases were more willing to delay pregnancy (99.0% vs 94.0%; <jats:italic>p<\/jats:italic>\u2009=\u20090.03). Combining vaccine trial attributes, 249 (89.6%) of the 278 accepted all attributes. After controlling for case\/ control status women with secondary education or higher expressed less WTP (aOR 0.17; 95% CI 0.04\u20130.80).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>FSWs in Kampala demonstrated high WTP. Prior experience with trial requirements like contraception may improve their uptake during actual trials. Family involvement is important for those without prior trial experience.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12889-020-09932-7","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T13:03:07Z","timestamp":1606309387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0414-1818","authenticated-orcid":false,"given":"Yunia","family":"Mayanja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Abaasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrude","family":"Namale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt A.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anatoli","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"9932_CR1","unstructured":"UNAIDS. UNAIDS data 2019. p. 2019. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2019-UNAIDS-data_en.pdf."},{"issue":"1","key":"9932_CR2","doi-asserted-by":"publisher","first-page":"196972","DOI":"10.23937\/2469-567X\/1510043","volume":"5","author":"R Granich","year":"2018","unstructured":"Granich R, Williams B, Gupta S, Zuniga JM. 90-90-90, epidemic control and ending AIDS: global situation and recommendations. Int J Virol AIDS. 2018;5(1):196972. https:\/\/doi.org\/10.23937\/2469-567X\/1510043.","journal-title":"Int J Virol AIDS"},{"issue":"5","key":"9932_CR3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New Engl J Med. 2012;367(5):399\u2013410. https:\/\/doi.org\/10.1056\/NEJMoa1108524.","journal-title":"New Engl J Med"},{"issue":"22","key":"9932_CR4","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. New Engl J Med. 2016;375(22):2121\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1506110.","journal-title":"New Engl J Med"},{"key":"9932_CR5","doi-asserted-by":"publisher","unstructured":"Montgomery ET, Stadler J, Naidoo S, Katz AW, Laborde N, Garcia M, et al. Reasons for non-adherence to the dapivirine vaginal ring: results of the MTN-032\/AHA study. AIDS. 2018. https:\/\/doi.org\/10.1097\/QAD.0000000000001868.","DOI":"10.1097\/QAD.0000000000001868"},{"issue":"1","key":"9932_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12879-018-3463-4","volume":"18","author":"D Sidebottom","year":"2018","unstructured":"Sidebottom D, Ekstr\u00f6m AM, Str\u00f6mdahl S. A systematic review of adherence to oral pre-exposure prophylaxis for HIV\u2013how can we improve uptake and adherence? BMC Infect Dis. 2018;18(1):581. https:\/\/doi.org\/10.1186\/s12879-018-3463-4.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"9932_CR7","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S2352-3018(18)30095-X","volume":"5","author":"DH Barouch","year":"2018","unstructured":"Barouch DH. A step forward for HIV vaccines. Lancet HIV. 2018;5(7):338\u20139. https:\/\/doi.org\/10.1016\/S2352-3018(18)30095-X.","journal-title":"Lancet HIV"},{"issue":"2","key":"9932_CR8","doi-asserted-by":"publisher","first-page":"N1","DOI":"10.1097\/QAD.0000000000001296","volume":"31","author":"KN Harper","year":"2017","unstructured":"Harper KN. HVTN100 phase 1\/2 vaccine trial results promising; phase 2b\/3 trial to commence. AIDS. 2017;31(2):N1\u20132. https:\/\/doi.org\/10.1097\/QAD.0000000000001296.","journal-title":"AIDS"},{"issue":"5\u20136","key":"9932_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/15284336.2017.1379676","volume":"18","author":"A Cutrell","year":"2017","unstructured":"Cutrell A, Donnell D, Dunn DT, Glidden DV, Grobler A, Hanscom B, et al. HIV prevention trial design in an era of effective pre-exposure prophylaxis. HIV Clin Trials. 2017;18(5\u20136):177\u201388. https:\/\/doi.org\/10.1080\/15284336.2017.1379676.","journal-title":"HIV Clin Trials"},{"key":"9932_CR10","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.socscimed.2018.11.027","volume":"220","author":"C Davey","year":"2019","unstructured":"Davey C, Dirawo J, Mushati P, Magutshwa S, Hargreaves JR, Cowan FM. Mobility and sex work: why, where, when? A typology of female-sex-worker mobility in Zimbabwe. Soc Sci Med. 2019;220:322\u201330. https:\/\/doi.org\/10.1016\/j.socscimed.2018.11.027.","journal-title":"Soc Sci Med"},{"issue":"4","key":"9932_CR11","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s10461-011-9985-z","volume":"16","author":"F Scorgie","year":"2012","unstructured":"Scorgie F, Chersich MF, Ntaganira I, Gerbase A, Lule F, Lo YR. Socio-demographic characteristics and behavioral risk factors of female sex workers in sub-saharan Africa: a systematic review. AIDS Behav. 2012;16(4):920\u201333. https:\/\/doi.org\/10.1007\/s10461-011-9985-z.","journal-title":"AIDS Behav"},{"issue":"15","key":"9932_CR12","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/j.vaccine.2016.02.048","volume":"34","author":"A Abaasa","year":"2016","unstructured":"Abaasa A, Asiki G, Price MA, Ruzagira E, Kibengo F, Bahemuka U, et al. Comparison of HIV incidence estimated in clinical trial and observational cohort settings in a high risk fishing population in Uganda: implications for sample size estimates. Vaccine. 2016;34(15):1778\u201385. https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.048.","journal-title":"Vaccine"},{"issue":"1","key":"9932_CR13","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1186\/1471-2458-14-986","volume":"14","author":"N Kiwanuka","year":"2014","unstructured":"Kiwanuka N, Mpendo J, Nalutaaya A, Wambuzi M, Nanvubya A, Kitandwe PK, et al. An assessment of fishing communities around Lake Victoria, Uganda, as potential populations for future HIV vaccine efficacy studies: an observational cohort study. BMC Public Health. 2014;14(1):986. https:\/\/doi.org\/10.1186\/1471-2458-14-986.","journal-title":"BMC Public Health"},{"issue":"1","key":"9932_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/QAI.0b013e3182777167","volume":"62","author":"J Vandepitte","year":"2013","unstructured":"Vandepitte J, Weiss HA, Bukenya J, Nakubulwa S, Mayanja Y, Matovu G, et al. Alcohol use, Mycoplasma genitalium and other STIs associated with HIV incidence among women at high risk in Kampala, Uganda. JAIDS (1999). 2013;62(1):119. https:\/\/doi.org\/10.1097\/QAI.0b013e3182777167.","journal-title":"JAIDS (1999)"},{"issue":"1","key":"9932_CR15","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1186\/s12879-019-4328-1","volume":"19","author":"Y Mayanja","year":"2019","unstructured":"Mayanja Y, Abaasa A, Namale G, Asiki G, Price MA, Kamali A. Factors associated with vaccination completion and retention among HIV negative female sex workers enrolled in a simulated vaccine efficacy trial in Kampala, Uganda. BMC Infect Dis. 2019;19(1):725. https:\/\/doi.org\/10.1186\/s12879-019-4328-1.","journal-title":"BMC Infect Dis"},{"issue":"44","key":"9932_CR16","doi-asserted-by":"publisher","first-page":"5055","DOI":"10.1016\/j.vaccine.2013.08.080","volume":"31","author":"G Asiki","year":"2013","unstructured":"Asiki G, Abaasa A, Ruzagira E, Kibengo F, Bahemuka U, Mulondo J, et al. Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda. Vaccine. 2013;31(44):5055\u201361. https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.080.","journal-title":"Vaccine"},{"issue":"1","key":"9932_CR17","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1186\/s12889-019-7822-x","volume":"19","author":"T Mbunda","year":"2019","unstructured":"Mbunda T, Tarimo EAM, Bakari M, Sandstr\u00f6m E, Kulane A. Recruitment using respondent driven sampling, risk behaviors assessment and willingness of young female sex workers (18\u201325 years) in Dar Es Salaam, Tanzania to participate in HIV vaccine trials. BMC Public Health. 2019;19(1):1537. https:\/\/doi.org\/10.1186\/s12889-019-7822-x.","journal-title":"BMC Public Health"},{"issue":"2","key":"9932_CR18","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1007\/s10461-012-0351-6","volume":"17","author":"B Metch","year":"2013","unstructured":"Metch B, Frank I, Novak R, Swann E, Metzger D, Morgan C, et al. Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trials. AIDS Behav. 2013;17(2):760\u201372. https:\/\/doi.org\/10.1007\/s10461-012-0351-6.","journal-title":"AIDS Behav"},{"issue":"8","key":"9932_CR19","doi-asserted-by":"publisher","first-page":"e0238028","DOI":"10.1371\/journal.pone.0238028","volume":"15","author":"EM Mutisya","year":"2020","unstructured":"Mutisya EM, Mutua G, Nyasani D, Nduta H, Kabuti RW, Muturi-Kioi V, et al. Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya. PLoS One. 2020;15(8):e0238028. https:\/\/doi.org\/10.1371\/journal.pone.0238028.","journal-title":"PLoS One"},{"issue":"11","key":"9932_CR20","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1080\/09540121.2011.555750","volume":"23","author":"S Dhalla","year":"2011","unstructured":"Dhalla S, Poole G. Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies. AIDS Care. 2011;23(11):1430\u201347. https:\/\/doi.org\/10.1080\/09540121.2011.555750.","journal-title":"AIDS Care"},{"key":"9932_CR21","doi-asserted-by":"publisher","unstructured":"Nyasani D, Mutua GN, Sajabi RM, Wairimu NJ, Gachie JN, Maina AM, et al. Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults\u2014experience from Kenya. PLoS One. 2018;13(11). https:\/\/doi.org\/10.1371\/journal.pone.0206656.","DOI":"10.1371\/journal.pone.0206656"},{"issue":"3","key":"9932_CR22","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s10461-017-1998-9","volume":"22","author":"Y Mayanja","year":"2018","unstructured":"Mayanja Y, Kamacooko O, Bagiire D, Namale G, Kaleebu P, Seeley J. \u2018Test and treat\u2019among women at high risk for HIV-infection in Kampala, Uganda: antiretroviral therapy initiation and associated factors. AIDS Behav. 2018;22(3):1053\u201361. https:\/\/doi.org\/10.1007\/s10461-017-1998-9.","journal-title":"AIDS Behav"},{"issue":"2","key":"9932_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/aid.2007.0312","volume":"25","author":"M Suhadev","year":"2009","unstructured":"Suhadev M, Nyamathi AM, Swaminathan S, Suresh A, Venkatesan P. Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India. AIDS Res Hum Retrovir. 2009;25(2):217\u201324. https:\/\/doi.org\/10.1089\/aid.2007.0312.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"2","key":"9932_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.4161\/hv.22903","volume":"9","author":"MF Etcheverry","year":"2013","unstructured":"Etcheverry MF, Evans JL, Sanchez E, Mendez-Arancibia E, Merono M, Gatell JM, et al. Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials. Hum Vaccin Immunother. 2013;9(2):420\u20139. https:\/\/doi.org\/10.4161\/hv.22903.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"9932_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12889-016-2875-6","volume":"16","author":"EAM Tarimo","year":"2016","unstructured":"Tarimo EAM, Bakari M, Kakoko DCV, Kohi TW, Mhalu F, Sandstrom E, et al. Motivations to participate in a phase I\/II HIV vaccine trial: a descriptive study from Dar es Salaam, Tanzania. BMC Public Health. 2016;16(1):182. https:\/\/doi.org\/10.1186\/s12889-016-2875-6.","journal-title":"BMC Public Health"},{"issue":"1","key":"9932_CR26","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1186\/1471-2458-13-741","volume":"13","author":"M Mbonye","year":"2013","unstructured":"Mbonye M, Nakamanya S, Nalukenge W, King R, Vandepitte J, Seeley J. \u2018It is like a tomato stall where someone can pick what he likes\u2019: structure and practices of female sex work in Kampala, Uganda. BMC Public Health. 2013;13(1):741. https:\/\/doi.org\/10.1186\/1471-2458-13-741.","journal-title":"BMC Public Health"},{"issue":"1","key":"9932_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10461-014-0957-y","volume":"19","author":"A Schwitters","year":"2015","unstructured":"Schwitters A, Swaminathan M, Serwadda D, Muyonga M, Shiraishi RW, Benech I, et al. Prevalence of rape and client-initiated gender-based violence among female sex workers: Kampala, Uganda, 2012. AIDS Behav. 2015;19(1):68\u201376. https:\/\/doi.org\/10.1007\/s10461-014-0957-y.","journal-title":"AIDS Behav"},{"issue":"1","key":"9932_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1744-8603-9-33","volume":"9","author":"F Scorgie","year":"2013","unstructured":"Scorgie F, Vasey K, Harper E, Ritcher M, Nare P, Maseko S, et al. Human rights abuses and collective resilience among sex workers in four African countries: a qualitative study. Glob Health. 2013;9(1):33. https:\/\/doi.org\/10.1186\/1744-8603-9-33.","journal-title":"Glob Health"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09932-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-020-09932-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-020-09932-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T13:18:19Z","timestamp":1606310299000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-020-09932-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["9932"],"URL":"https:\/\/doi.org\/10.1186\/s12889-020-09932-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"24 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Uganda National Council for Science and Technology (HS 1584) and Uganda Virus Research Institute-Research Ethics Committee (GC\/127\/14\/04\/454) approved the study. We obtained written informed consent from all participants who took part in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1789"}}